Recon: Sanofi, GKS report positive interim results for COVID shot; Regeneron resumes lymphoma trials
The Pharma Data
MAY 17, 2021
Regeneron resumes enrollment in lymphoma drug trials ( Reuters ). Incyte’s vitiligo treatment meets main goal in late-stage trial ( Reuters ). US Supreme Court denies Sandoz petition to review biosimilar Erelzi case ( Press ). Now they fear an increase. BioPharmaDive ).
Let's personalize your content